top of page

OTTAVA vs da Vinci 5: What's the Difference?

Aug 12
4 min read

Updated: 50 minutes ago

Ottava vs. da Vinci 5: The Two Soft-Tissue Robots Redefining the OR

Robotic surgery has followed the same basic architecture for decades: a patient-side cart, robotic arms around the operating table, and a separate surgeon console.


Ottava changes that architecture. Its four robotic arms are integrated directly into the operating table.


da Vinci 5 keeps the cart but adds new capabilities, including force feedback, substantially greater computing capacity, and expanded software and data capabilities.


Both now have FDA authorization or clearance for specific soft-tissue procedures in the United States. They represent two different approaches to the next generation of multi-port robotic surgery.


To choose between these systems for your hospital, use The Surgical Robot Buyer's Guide.


Two architectures


Ottava integrates four robotic arms into the operating table. The arms can be stowed beneath the table, while Twin Motion synchronizes the table and robotic arms during repositioning.


da Vinci 5 uses a conventional four-arm patient-side cart.


The difference is simple:


Ottava integrates the robot into the table. da Vinci 5 keeps the robot and table separate.

That decision affects OR footprint, positioning, and workflow.


Space and workflow


Johnson & Johnson says Ottava occupies 30–50% less floor space than traditional boom- and cart-mounted systems. During its pivotal clinical study, the company reported use in ORs ranging from approximately 243 to 694 square feet.


Twin Motion extends the same idea to patient positioning, coordinating the table and robotic arms so the patient can be repositioned without the conventional separation between table movement and robotic setup.


da Vinci 5 remains cart-based.


For hospitals with constrained OR space, this is one of Ottava's clearest potential advantages.


Force Feedback vs. Twin Motion


da Vinci 5's signature technology is Force Feedback.


Sensors near compatible instrument tips measure applied forces and transmit that information to the surgeon's hand controllers.


In preclinical studies involving 28 surgeons, Intuitive reported up to 43% less force applied to tissue with Force Feedback. The studies evaluated simulated surgical tasks rather than patient outcomes.


Ottava takes a different approach. Its signature technology is Twin Motion, which synchronizes the operating table with the four robotic arms. This allows the team to reposition the patient while the robot moves with the table.


The difference is simple:


Ottava changes how the robot moves. da Vinci 5 changes what the surgeon can feel.

Computing and software


Intuitive says da Vinci 5 has more than 10,000 times the computing power of da Vinci Xi, supporting capabilities such as Force Gauge, Case Insights, and video replay.


Ottava has its own digital ecosystem through Polyphonic.


The difference today is maturity: da Vinci 5 already has a broader established software and data ecosystem, while Ottava is building one around a new platform.


FDA status and scope


The FDA granted OTTAVA De Novo authorization on July 22, 2026.


De Novo is the pathway for a new type of device that has no existing equivalent to compare against.


The authorized procedures are Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication, and hiatal hernia repair.


Johnson & Johnson plans to launch with select U.S. customers first, then expand to more indications and regions.


A U.S. clinical trial for inguinal hernia repair is ongoing.


da Vinci 5 has a broader established multi-specialty footprint across urology, gynecology, general surgery, and thoracic surgery.


What the evidence shows


The press release cites no clinical outcome data.


Its supporting references are internal company documents, so every benefit it describes is a company statement and not an independent result.


The inguinal hernia trial is the next place real outcome data could appear.


Ottava vs. da Vinci 5 at a Glance


Feature

Ottava

da Vinci 5

Architecture

4 robotic arms integrated into operating table

4 robotic arms on patient-side cart

Key technology

Twin Motion

Force Feedback

OR footprint

30–50% less than traditional boom/cart systems*

Reduced vs. da Vinci Xi

Patient repositioning

Table and robotic arms move together

Conventional table/cart configuration

Instruments

Ethicon

Intuitive, 7 degrees of freedom

Computing

New platform

>10,000× da Vinci Xi

Digital ecosystem

Polyphonic

Force Gauge, Case Insights, video replay

Console

Apollo Console

Redesigned adjustable console

FDA status

De Novo authorization, July 2026

FDA-cleared

Initial U.S. scope

Upper-abdominal general surgery

Multi-specialty

Commercial position

Limited U.S. launch

Established da Vinci ecosystem

*According to Johnson & Johnson, compared with traditional boom- and cart-mounted systems.


The bigger difference


Ottava and da Vinci 5 are solving different problems.


Ottava changes the physical architecture of robotic surgery.


da Vinci 5 adds sensing, computing, and software to an established architecture.


For a hospital with limited OR space, Ottava's architecture may be the more significant change.


For a hospital already invested in da Vinci, the da Vinci 5 offers greater capabilities without abandoning the existing ecosystem.


Neither system is autonomous. Both remain surgeon-controlled platforms.


Both sit at the same rung on the autonomy ladder.


Ottava is the bigger architectural shift. da Vinci 5 is the more mature platform.

That is the real difference between them.


For the full picture across regulation, companies, and evidence, read The 2026 Surgical Technology Intelligence Report.



The sourced claims for Ottava, Hugo, and Versius are listed in the Surgical AI & Robotics Database.


Sources



Related reading:





Weekly Newsletter

Surgical Tech Radar

The innovations reshaping the operating room, curated and verified, delivered to your inbox.

  • New surgical AI tools and robotics, tracked weekly
  • Verified claims separated from hype
  • Concise briefings built for busy surgeons

Free forever. No spam. Unsubscribe anytime.

bottom of page